{
  "url": "https://openlegislation.uk/draft-health-services-cross-border-health-care-and-miscellaneous-amendments-northern-ireland-eu-exit-regulations-2019/schedule-1/paragraph-1",
  "json_url": "https://openlegislation.uk/draft-health-services-cross-border-health-care-and-miscellaneous-amendments-northern-ireland-eu-exit-regulations-2019/schedule-1/paragraph-1.json",
  "legislation": "ukdsi/2019/9780111180808",
  "legislation_title": "The Health Services (Cross-Border Health Care and Miscellaneous Amendments) (Northern Ireland) (EU Exit) Regulations 2019",
  "legislation_url": "https://openlegislation.uk/draft-health-services-cross-border-health-care-and-miscellaneous-amendments-northern-ireland-eu-exit-regulations-2019",
  "path": "schedule/1/paragraph/1",
  "kind": "paragraph",
  "number": "1",
  "heading": null,
  "text": "The modifications of the 2013 Regulations referred to in regulation 16 are that those Regulations are to be read as if—\n(a) in regulation 2 (interpretation)—\n(i) in the definition of “resident patient”, for “the United Kingdom is” there were substituted “immediately before exit day the United Kingdom was”;\n(ii) in the definition of “visiting patient”, for “a member State other than the United Kingdom is” there were substituted “immediately before exit day a member State other than the United Kingdom was”;\n(b) in the heading to regulation 5 (national contact point: information about treatment in another member State), for “another member State” there were substituted “a member State”;\n(c) in regulation 5—\n(i) for references to “other member States” there were substituted “member States”;\n(ii) for the reference to “another member State” there were substituted “a member State”;\n(d) regulation 5A (National Contact Point: information about prescriptions intended to be used in another member State) were omitted;\n(e) for regulation 6(1) (National Contact Point: cross-border co-operation) there were substituted—\n“(1) In so far as it considers it appropriate for the purposes of giving effect to regulation 16 of the National Health Service (Cross-Border Healthcare and Miscellaneous Amendments etc) (EU Exit) Regulations 2019, the NCP must co-operate with the national contact points in member States and any other national contact points established in the United Kingdom.”;\n(f) regulation 7 (National Contact Point: duty to consult) were omitted;\n(g) in regulation 12—\n(i) in paragraph (2) for “P is” there were substituted “immediately before exit day P was”;\n(ii) in paragraph (2)(a), for “is resident” there were substituted “was resident”;\n(iii) in paragraph (2)(b), for “is the competent member State” there were substituted “was the competent member State”;\n(iv) in paragraph (4)(b) at the end there were inserted “as it had effect immediately before exit day”;\n(h) the schedule (elements that must be included in prescriptions intended to be used in another member State) were omitted.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2019/9780111180808/schedule/1/paragraph/1",
    "retrieved_at": "2026-10-30T15:00:42.926372+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}